Association of Osteopontin With Specific Prognostic Factors and Survival in Adjuvant Breast Cancer Trials of the Hellenic Cooperative Oncology Group

Osteopontin (OPN) is a matricellular protein that has been suggested to be a potential biomarker in BC. Researchers from a recent study found that high OPN mRNA expression is associated with decreased disease-free survival and overall survival in a large cohort of patients with breast cancer treated with adjuvant chemotherapy.

 J Transl Med

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.